Crimping-induced structural gradients explain the lasting strength of poly L-lactide bioresorbable vascular scaffolds during hydrolysis
Abstract
Biodegradable polymers open the way to treatment of heart disease using transient implants (bioresorbable vascular scaffolds, BVSs) that overcome the most serious complication associated with permanent metal stents—late stent thrombosis. Here, we address the long-standing paradox that the clinically approved BVS maintains its radial strength even after 9 mo of hydrolysis, which induces a ∼40% decrease in the poly L-lactide molecular weight (Mn). X-ray microdiffraction evidence of nonuniform hydrolysis in the scaffold reveals that regions subjected to tensile stress during crimping develop a microstructure that provides strength and resists hydrolysis. These beneficial morphological changes occur where they are needed most—where stress is localized when a radial load is placed on the scaffold. We hypothesize that the observed decrease in Mn reflects the majority of the material, which is undeformed during crimping. Thus, the global measures of degradation may be decoupled from the localized, degradation-resistant regions that confer the ability to support the artery for the first several months after implantation.
Additional Information
© 2018 The Author(s). Published under the PNAS license. Edited by Frank S. Bates, University of Minnesota, Minneapolis, MN, and approved August 17, 2018 (received for review May 9, 2018). PNAS published ahead of print September 17, 2018 https://doi.org/10.1073/pnas.1807347115 We thank Dr. Zhonghou Cai (Advanced Photon Source, APS) for his assistance in collecting X-ray microdiffraction data and Troy Carter (Abbott Vascular) for sectioning the scaffolds. This research used resources of the APS, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work was supported by Abbott Vascular, the Jacobs Institute for Molecular Engineering for Medicine, and the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award F31HL137308. Author contributions: K.R. and J.A.K. designed research; K.R. and T.D.L. performed research; A.A., M.B.K., and J.P.O. contributed new reagents/analytic tools; K.R. and J.A.K. analyzed data; and K.R. and J.A.K. wrote the paper. Conflict of interest statement: M.B.K. and J.P.O. are employees of Abbott Vascular. Funding for this research was provided by Abbott Vascular. This article is a PNAS Direct Submission. This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1807347115/-/DCSupplemental.Attached Files
Published - 10239.full.pdf
Supplemental Material - pnas.1807347115.sapp.pdf
Files
Name | Size | Download all |
---|---|---|
md5:8cfabe33c9851c311c585136dd798d9e
|
54.7 MB | Preview Download |
md5:22030dbc690fcbf7b1bbcb583e9401f6
|
2.4 MB | Preview Download |
Additional details
- PMCID
- PMC6187115
- Eprint ID
- 89697
- DOI
- 10.1073/pnas.1807347115
- Resolver ID
- CaltechAUTHORS:20180918-095157859
- Department of Energy (DOE)
- DE-AC02-06CH11357
- Abbott Vascular
- Jacobs Institute for Molecular Engineering for Medicine
- NIH Postdoctoral Fellowship
- F31HL137308
- Created
-
2018-09-18Created from EPrint's datestamp field
- Updated
-
2022-03-07Created from EPrint's last_modified field
- Caltech groups
- Jacobs Institute for Molecular Engineering for Medicine